Trade Summary

Yesterday, Dahl Andrew M., serving as SVP, Corporate Controller at Edwards Lifesciences Corp (EW), sold 568 shares at $86.08 per share, for a total transaction value of $48,852.69. Following this transaction, Dahl Andrew M. now holds 15,334 shares of EW.

This sale represents a 3.57% decrease in Dahl Andrew M.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 29, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 29, 2026 at 4:44 PM ET, meaning the disclosure happened on the same day as the trade.

Edwards Lifesciences Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.